Available · Spring 2026

Systems
that shape
care.

I'm Shri: healthcare professional, epidemiologist, and strategist. I spent a year treating patients before realizing the biggest lever sits upstream. Now I use data, product, and evidence to fix the systems around them.

3.94 Dual MPH / MBA
Olin MBA Healthcare Strategy
ASCO 2026 presenter
Scroll
Shri portrait
The Story

Hi, I'm Shri.
A healthcare professional
who left the clinic to fix it.

I practiced medicine for a year in India. I saw patients, wrote prescriptions, redesigned a clinic's EHR. And somewhere in that year I noticed something that wouldn't leave me alone.

The most important decisions about my patients weren't made by me. They were made by the systems around me: who gets screened, what gets covered, how data flows between a hospital and an insurer. The doctor is one node in a much larger network. I wanted to understand that network.

So I left clinical practice, moved to St. Louis, and started a dual MPH/MBA at Washington University. Since then I've done cancer survival research at Siteman, built a health‑tech product from zero with AI as a co‑architect, written a rural-hospital turnaround case for an Olin healthcare management course, and had a first-author study accepted at ASCO 2026.

The work takes a lot of shapes now: Cox models on 20 years of NHANES, a chronic‑care app built spec‑first with AI in the loop, hospital financial turnarounds, and a locally‑run AI pipeline producing long‑form health video on a single GPU. The method stays the same: spec first, locked decisions, primary sources cited, AI as a co‑builder, never a crutch.

Every project comes back to the same question: how do we make the system work better for the people inside it?

In the margins
 
 
How I Work

I build with AI,
not around it.

Every project starts from a written specification in plain Markdown: research synthesis, thresholds, edge cases, locked decisions, all captured before the first file is written. Code follows the spec, not the other way around.

01

Spec‑driven development

Research, thresholds, and edge cases are locked in a plain Markdown spec before any code is written. Open‑ended prompts produce debt; locked prompts produce verifiable output.

02

Multi‑chat AI orchestration

Parallel AI chats for different phases of a single project: research, architecture, implementation review, prompt drafting. Each chat holds its own context; artifacts feed the others. Decisions stay traceable across the build.

03

Instrumented before expanded

I defer architectural complexity until telemetry justifies it. New data sources, new services, new layers all wait on evidence from the baseline. One step per agentic session, verified on device before the next one starts.

04

Clinical grounding

Health‑domain thresholds come from primary guidelines (ADA, AHA, DASH, NHLBI, WHO, CDC, FDA). Cited inline, evidence grades flagged, edge cases worked, never paraphrased from secondary summaries.

Selected Work

From clinical questions
to working products.

Every project here started with a real problem and ended with something I built from scratch: a product, a model, a financial roadmap, a published result.

Featured · Health Tech

Nyrocare,
chronic care,
reimagined.

An AI‑powered chronic disease companion for medication adherence, nutrition tracking, and clinical decision support. Built from zero to working product through WashU Skandalaris Center.

50+ Interviews
19 Services
18 Screens
Read the case study
Nyrocare weekly metrics
Nyrocare home
Nyrocare Nora AI coach
Nyrocare · Home, Insights, Nora
0 yr 20 yr KAPLAN-MEIER SURVIVAL Kaplan-Meier curve Live Dashboard
Cancer Epidemiology · Self-directed

Cancer survival and cardiometabolic burden

Cox PH analysis on NHANES 1999 to 2018 (n = 51,168). Diabetes raises all-cause mortality 31% in cancer survivors after full adjustment (HR 1.31, 95% CI 1.17 to 1.47).

Survival analysis NHANES
BJC LCS COHORT · 2015 to 2023 66% ON LIPID-LOWERING THERAPY 34% PREVENTION GAP · n = 7,778 ASCO 2026 · Accepted
ASCO 2026 · Lead author

Lipid-lowering therapy in cancer survivors undergoing lung cancer screening

BJC HealthCare LCS EHR cohort, 2015 to 2023 (n = 7,778). Multivariable logistic regression. Prior ASCVD AOR 2.54 (2.29 to 2.81); rural residence AOR 0.71 (0.62 to 0.82). With Dr. Beryne Odeny, Siteman Cancer Center.

BJC EHR Logistic regression
OR = 1.0 BP control 1.26 A1c control 1.33 High chol 0.86 Adjusted odds ratios Live Dashboard
Survivorship Care

Cardiovascular risk in cancer survivors

Survey‑weighted logistic regression on 51,168 NHANES adults. Survivors have 26% better BP control and 33% better A1c control.

Logistic regression NHANES
HR = 1.0 Unadjusted 2.86 PS‑Matched 1.24 IPTW 1.02 CONFOUNDING RESOLVED HR · unadjusted → adjusted
Causal Inference

Propensity score analysis

Matching, IPTW, and doubly robust estimation for treatment effects from observational data (NHANES, n = 18,129). Love plots, PH tests, sensitivity analyses.

Causal inference Python
9.5× MARKUP SPREAD MD US CA NV Payment Charges State markup · CY 2022 Live Dashboard
Health Policy

Medicare rate analysis

550K sepsis discharges, 9.5× charge‑to‑payment spread across states. What CY 2022 Medicare claims reveal about rate‑setting.

Claims data Policy
AUC = 0.852 False positive rate True positive rate ROC · AUC
ML for Health

Diabetes risk prediction · I2DB Datathon

XGBoost model predicting uncontrolled diabetes from EHR data. SHAP explanations, fairness tested across race, sex, age, and insurance.

XGBoost Fairness
12-MONTH TURNAROUND PLAN -$27M YEAR 0 LOSS YEAR 1 PLAN +$3M EBITDA Olin course case
Healthcare Strategy · Olin course case

Madera Community Hospital turnaround memo

Solo strategic memo for the only general hospital serving Madera County, California (closed January 2023, reopening on a $57M state bridge loan). Public data only (IRS Form 990 EIN 23-7429117, California HCAI). Four coordinated interventions to flip a $27M operating loss to $3M EBITDA in year one.

Course case Strategy Turnaround
MARKET ENTRY ST. LOUIS Home base BARCELONA Entry market 3‑YEAR PRO FORMA · €192K Market entry · EU
Business Strategy

Strange Donuts · Barcelona entry

Full market entry strategy for a US food brand expanding into Spain. Site selection, consumer research, and a 3‑year financial model.

Market entry Pro forma
Tools & Stack

Built with intent.

Not an exhaustive list, just the tools I actually reach for. TypeScript strict mode, SAS and Stata for survey analysis, Ollama for offline LLM inference on a consumer GPU, FFmpeg‑assembled video, and Claude in every phase of the build.

Experience

Where I've
done the work.

Consulting, clinical practice, and academic research: each project taught me how a different layer of the healthcare system actually operates.

Cancer Epi Research Fellow
Siteman Cancer Center
Jun 2024 to Present

Lead author on a BJC HealthCare lung cancer screening cohort study examining lipid-lowering therapy use in cancer survivors, accepted at ASCO 2026 (with Dr. Beryne Odeny). Independent NHANES 1999 to 2018 survival analyses on cardiometabolic burden in cancer survivors.

Healthcare Research Analyst
Stats Lab, WashU
Jul 2024 to Present

Claims data analysis, biostatistics consulting, and methodology support for public health faculty across multiple ongoing studies.

Graduate Venture Project Lead
Nyrocare · WashU Skandalaris Center
May 2024 to Present

Built from zero through 50+ user interviews. React Native app, 19 integrated services, voice AI companion for chronic disease management.

Healthcare Strategy Case Author
Olin Business School, WashU
2024

Solo strategic turnaround memo for Madera Community Hospital, the only general hospital in Madera County, California, closed January 2023 and reopening on a $57M state bridge loan. Built from public data (IRS Form 990 EIN 23-7429117, California HCAI). Four interventions (reopen ED and OB, renegotiate commercial contracts, in-house nursing pool, Community Partnership Council) projected to flip a $27M operating loss to $3M EBITDA in year one. Olin healthcare management course case.

Board Member
Community Care Center, Illinois
Jan 2024 to Jan 2026

Governance oversight for an FQHC. Reviewed financials, strategic plans, and quality metrics across two years.

Medical Officer
ANR Poly Clinic, India
Jun 2022 to Jun 2023

One year of outpatient medicine. Redesigned the clinic's EHR intake workflow and founded an 800+ member mentoring community.

Teaching Assistant
Public Health Seminar II · WashU MPH
Spring 2026

Graduate‑level seminar on research methods and evidence‑based practice.

Research

Published,
peer‑reviewed.

Cancer outcomes, health equity, and chronic disease: my research sits at the intersection of clinical medicine and population health.

Lipid-lowering therapy in cancer survivors undergoing lung cancer screening poster, ASCO 2026
ASCO 2026 · Accepted
Lipid-lowering therapy in cancer survivors undergoing lung cancer screening
Disparities in cervical cancer screening among women with and without a history of cancer poster, BRFSS 2024
WashU GRS · Poster
Disparities in cervical cancer screening among women with and without a history of cancer (BRFSS 2024)
Research Stats

By the numbers

  • 2 conference posters
  • 1 ASCO 2026 accepted presentation
  • 5 peer reviewerships
  • Publications in progress
Topic Areas

Research focus

Cancer Epidemiology Real World Evidence Survival Analysis Claims Data Health Systems Research Biostatistics
Education

Clinical training,
systems thinking.

A medical degree, a public health master's, and an MBA: three lenses on the same question: how do we fix the system around the patient?

MBA · Dual Degree
Olin Business School
Washington University in St. Louis · Class of 2026
Healthcare strategy and finance. Graduate Policy Scholar.
MPH · Epidemiology
School of Public Health
Washington University in St. Louis · Class of 2026 · 3.94 GPA
Epidemiology and biostatistics concentration. Delta Omega Honor Society.
BNYS · Medical Degree
SDM College
Karnataka, India · 2016 to 2022
Bachelor of Naturopathy and Yogic Sciences. One year of clinical practice post‑graduation at ANR Poly Clinic.
Shri with MBA cohort at WashU Olin Business School
WashU Olin · MBA cohort
Delta Omega Honor Society Class Acts Award ASCO 2026 Accepted CPH Certified Graduate Policy Scholar 3.94 GPA 5 Languages
Beyond Work

Off the clock,
still curious.

I cook my way through regional Indian cookbooks, chase dark skies for stargazing, and read more health‑policy white papers than is probably healthy.

Stargazer Home cook Policy nerd Trail runner Book hoarder
Let's talk

Working on
a system problem?
Let's talk.

I'm interested in healthcare strategy, product, and research roles starting summer 2026. If you're working on something hard, I'd love to hear about it.